

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | transepithelial transport (GO:0070633) | 7.13304518 |
| 2 | thalamus development (GO:0021794) | 6.83977749 |
| 3 | polyamine biosynthetic process (GO:0006596) | 6.25362385 |
| 4 | cellular biogenic amine catabolic process (GO:0042402) | 6.00562048 |
| 5 | amine catabolic process (GO:0009310) | 6.00562048 |
| 6 | regulation of interleukin-8 secretion (GO:2000482) | 5.85626999 |
| 7 | negative regulation of appetite (GO:0032099) | 5.40891630 |
| 8 | negative regulation of response to food (GO:0032096) | 5.40891630 |
| 9 | regulation of hexokinase activity (GO:1903299) | 5.31524095 |
| 10 | regulation of glucokinase activity (GO:0033131) | 5.31524095 |
| 11 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.16738174 |
| 12 | pantothenate metabolic process (GO:0015939) | 5.04542535 |
| 13 | opsonization (GO:0008228) | 4.94112978 |
| 14 | amine biosynthetic process (GO:0009309) | 4.71796234 |
| 15 | cellular biogenic amine biosynthetic process (GO:0042401) | 4.67979793 |
| 16 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.55632832 |
| 17 | cardiolipin metabolic process (GO:0032048) | 4.40867538 |
| 18 | regulation of platelet aggregation (GO:0090330) | 4.19616907 |
| 19 | bicarbonate transport (GO:0015701) | 4.09504034 |
| 20 | polyamine metabolic process (GO:0006595) | 4.03777092 |
| 21 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.02050733 |
| 22 | peroxisome fission (GO:0016559) | 3.98183234 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.92616504 |
| 24 | arginine catabolic process (GO:0006527) | 3.88796827 |
| 25 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.83168449 |
| 26 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.81774969 |
| 27 | positive regulation of vasodilation (GO:0045909) | 3.67475148 |
| 28 | ADP metabolic process (GO:0046031) | 3.66116151 |
| 29 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.65016593 |
| 30 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.63469308 |
| 31 | response to lead ion (GO:0010288) | 3.62795926 |
| 32 | retinal cone cell development (GO:0046549) | 3.53090696 |
| 33 | urate metabolic process (GO:0046415) | 3.52335974 |
| 34 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.51030472 |
| 35 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.51030472 |
| 36 | dopamine transport (GO:0015872) | 3.50638489 |
| 37 | regulation of response to food (GO:0032095) | 3.46804462 |
| 38 | vasodilation (GO:0042311) | 3.43837127 |
| 39 | negative regulation of heart rate (GO:0010459) | 3.40967548 |
| 40 | one-carbon compound transport (GO:0019755) | 3.40285949 |
| 41 | negative regulation of lipid storage (GO:0010888) | 3.31955695 |
| 42 | adenosine metabolic process (GO:0046085) | 3.29634474 |
| 43 | nephron tubule formation (GO:0072079) | 3.27617885 |
| 44 | chronic inflammatory response (GO:0002544) | 3.27418693 |
| 45 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.26528747 |
| 46 | negative regulation of interleukin-8 production (GO:0032717) | 3.26234036 |
| 47 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.25512217 |
| 48 | regulation of appetite (GO:0032098) | 3.24358905 |
| 49 | response to methylmercury (GO:0051597) | 3.22462838 |
| 50 | nucleoside diphosphate catabolic process (GO:0009134) | 3.20360912 |
| 51 | negative regulation of complement activation (GO:0045916) | 3.18525001 |
| 52 | ribonucleoside diphosphate metabolic process (GO:0009185) | 3.15977457 |
| 53 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.15088412 |
| 54 | transmission of nerve impulse (GO:0019226) | 3.13922424 |
| 55 | modulation by virus of host process (GO:0019054) | 3.13338507 |
| 56 | temperature homeostasis (GO:0001659) | 3.11821184 |
| 57 | membrane hyperpolarization (GO:0060081) | 3.11701675 |
| 58 | sperm capacitation (GO:0048240) | 3.10159960 |
| 59 | acute inflammatory response (GO:0002526) | 3.04600026 |
| 60 | lipoxygenase pathway (GO:0019372) | 3.04221974 |
| 61 | linoleic acid metabolic process (GO:0043651) | 3.00996829 |
| 62 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00657493 |
| 63 | type B pancreatic cell proliferation (GO:0044342) | 2.99826346 |
| 64 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.98618934 |
| 65 | regulation of sensory perception (GO:0051931) | 2.98166051 |
| 66 | regulation of sensory perception of pain (GO:0051930) | 2.98166051 |
| 67 | indole-containing compound catabolic process (GO:0042436) | 2.98111341 |
| 68 | indolalkylamine catabolic process (GO:0046218) | 2.98111341 |
| 69 | tryptophan catabolic process (GO:0006569) | 2.98111341 |
| 70 | photoreceptor cell maintenance (GO:0045494) | 2.96642961 |
| 71 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.96329166 |
| 72 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.95038799 |
| 73 | negative regulation of platelet activation (GO:0010544) | 2.91194647 |
| 74 | regulation of platelet activation (GO:0010543) | 2.88555769 |
| 75 | cellular response to virus (GO:0098586) | 2.86968259 |
| 76 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.82161166 |
| 77 | superoxide anion generation (GO:0042554) | 2.82036055 |
| 78 | negative regulation of protein activation cascade (GO:2000258) | 2.80013168 |
| 79 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.78389709 |
| 80 | negative regulation of neurotransmitter transport (GO:0051589) | 2.77703890 |
| 81 | leukocyte tethering or rolling (GO:0050901) | 2.76438672 |
| 82 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.69090294 |
| 83 | response to epinephrine (GO:0071871) | 2.67025645 |
| 84 | prenylation (GO:0097354) | 2.66708523 |
| 85 | protein prenylation (GO:0018342) | 2.66708523 |
| 86 | positive regulation of glomerulus development (GO:0090193) | 2.64865237 |
| 87 | regulation of endothelial cell differentiation (GO:0045601) | 2.63306684 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 2.63193196 |
| 89 | negative regulation of response to extracellular stimulus (GO:0032105) | 2.62775701 |
| 90 | negative regulation of response to nutrient levels (GO:0032108) | 2.62775701 |
| 91 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.61426434 |
| 92 | tryptophan metabolic process (GO:0006568) | 2.60252121 |
| 93 | carnitine metabolic process (GO:0009437) | 2.58518331 |
| 94 | positive regulation of macrophage differentiation (GO:0045651) | 2.58298793 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 2.57915539 |
| 96 | reactive oxygen species biosynthetic process (GO:1903409) | 2.56869778 |
| 97 | establishment of skin barrier (GO:0061436) | 2.56518223 |
| 98 | glycosphingolipid biosynthetic process (GO:0006688) | 2.55737900 |
| 99 | cellular response to nicotine (GO:0071316) | 2.54305282 |
| 100 | renal tubule morphogenesis (GO:0061333) | 2.53485624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.00389000 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.59652052 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.56424469 |
| 4 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.71602571 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.64611900 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.45634279 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12227062 |
| 8 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.10436249 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.06708957 |
| 10 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.04812233 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.02959989 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00164966 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 1.94590241 |
| 14 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.94398401 |
| 15 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.94398401 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93084861 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.89844868 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89278501 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.86570934 |
| 20 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.84865945 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82899453 |
| 22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.81530112 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74476300 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.71715042 |
| 25 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.70775337 |
| 26 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.69212287 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68815782 |
| 28 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.67427654 |
| 29 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.59090856 |
| 30 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57337203 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.56892028 |
| 32 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.46424347 |
| 33 | TP53_16413492_ChIP-PET_HCT116_Human | 1.44760989 |
| 34 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43750035 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43367939 |
| 36 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40674945 |
| 37 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40500958 |
| 38 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38714319 |
| 39 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37898980 |
| 40 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.35648737 |
| 41 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35359809 |
| 42 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35299687 |
| 43 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34848657 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29985093 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29931759 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29650416 |
| 47 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29565429 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29054786 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28969056 |
| 50 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.27980252 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27909010 |
| 52 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.26674641 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26459561 |
| 54 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25790016 |
| 55 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23864605 |
| 56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23707440 |
| 57 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23280957 |
| 58 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.22951929 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.20877155 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19333643 |
| 61 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.19183593 |
| 62 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17812916 |
| 63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16432891 |
| 64 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16417841 |
| 65 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15822825 |
| 66 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14884710 |
| 67 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14884710 |
| 68 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13570782 |
| 69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12548889 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11653825 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11537656 |
| 72 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09605930 |
| 73 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09323494 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09009770 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09009770 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07961083 |
| 77 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.07425071 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07389190 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06963485 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06941220 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06400901 |
| 82 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06394304 |
| 83 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.06081866 |
| 84 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06018068 |
| 85 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.05592226 |
| 86 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.05537876 |
| 87 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.05374928 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05329687 |
| 89 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03700263 |
| 90 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03700263 |
| 91 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02993803 |
| 92 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02517603 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02509056 |
| 94 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02062117 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01883116 |
| 96 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00843006 |
| 97 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.99604739 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99498792 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98135448 |
| 100 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97701378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 5.93330696 |
| 2 | MP0008004_abnormal_stomach_pH | 5.64794987 |
| 3 | MP0003300_gastrointestinal_ulcer | 5.56855472 |
| 4 | MP0002163_abnormal_gland_morphology | 4.91802858 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.36138851 |
| 6 | MP0003252_abnormal_bile_duct | 4.19266983 |
| 7 | MP0010386_abnormal_urinary_bladder | 3.94239250 |
| 8 | MP0002132_abnormal_respiratory_system | 3.88367847 |
| 9 | MP0004043_abnormal_pH_regulation | 3.06092063 |
| 10 | MP0002736_abnormal_nociception_after | 2.91810727 |
| 11 | MP0003724_increased_susceptibility_to | 2.69451048 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 2.64293610 |
| 13 | MP0001664_abnormal_digestion | 2.60528076 |
| 14 | MP0005379_endocrine/exocrine_gland_phen | 2.59526115 |
| 15 | MP0005083_abnormal_biliary_tract | 2.57117307 |
| 16 | MP0005365_abnormal_bile_salt | 2.42745393 |
| 17 | MP0008872_abnormal_physiological_respon | 2.30137110 |
| 18 | MP0005084_abnormal_gallbladder_morpholo | 2.23176575 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.15992251 |
| 20 | MP0005670_abnormal_white_adipose | 2.12594585 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 1.96067761 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 1.95441437 |
| 23 | MP0004084_abnormal_cardiac_muscle | 1.92384124 |
| 24 | MP0008569_lethality_at_weaning | 1.70779031 |
| 25 | MP0001968_abnormal_touch/_nociception | 1.65928131 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 1.52492292 |
| 27 | MP0002928_abnormal_bile_duct | 1.52283291 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.50902922 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.50774534 |
| 30 | MP0009764_decreased_sensitivity_to | 1.42097814 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.38493404 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.38493404 |
| 33 | MP0005410_abnormal_fertilization | 1.35969289 |
| 34 | MP0000613_abnormal_salivary_gland | 1.23825925 |
| 35 | MP0003195_calcinosis | 1.21462426 |
| 36 | MP0003646_muscle_fatigue | 1.19918210 |
| 37 | MP0001663_abnormal_digestive_system | 1.18308472 |
| 38 | MP0005220_abnormal_exocrine_pancreas | 1.15209095 |
| 39 | MP0004142_abnormal_muscle_tone | 1.14133966 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.13417603 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.11982170 |
| 42 | MP0000538_abnormal_urinary_bladder | 0.99601409 |
| 43 | MP0003303_peritoneal_inflammation | 0.98400536 |
| 44 | MP0003718_maternal_effect | 0.93511454 |
| 45 | MP0000462_abnormal_digestive_system | 0.86984546 |
| 46 | MP0001177_atelectasis | 0.84456650 |
| 47 | MP0010329_abnormal_lipoprotein_level | 0.82755452 |
| 48 | MP0001501_abnormal_sleep_pattern | 0.80821918 |
| 49 | MP0008874_decreased_physiological_sensi | 0.80045222 |
| 50 | MP0003950_abnormal_plasma_membrane | 0.78775993 |
| 51 | MP0002733_abnormal_thermal_nociception | 0.78135149 |
| 52 | MP0001486_abnormal_startle_reflex | 0.77720170 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 0.77618012 |
| 54 | MP0000343_altered_response_to | 0.73745831 |
| 55 | MP0005595_abnormal_vascular_smooth | 0.72967051 |
| 56 | MP0003137_abnormal_impulse_conducting | 0.71399904 |
| 57 | MP0008877_abnormal_DNA_methylation | 0.71169111 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 0.67883961 |
| 59 | MP0002249_abnormal_larynx_morphology | 0.66059369 |
| 60 | MP0005174_abnormal_tail_pigmentation | 0.64710634 |
| 61 | MP0001270_distended_abdomen | 0.63485593 |
| 62 | MP0005381_digestive/alimentary_phenotyp | 0.62916762 |
| 63 | MP0003045_fibrosis | 0.62698063 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.61949680 |
| 65 | MP0004085_abnormal_heartbeat | 0.61854485 |
| 66 | MP0001970_abnormal_pain_threshold | 0.60986210 |
| 67 | MP0004233_abnormal_muscle_weight | 0.60235122 |
| 68 | MP0003186_abnormal_redox_activity | 0.59940901 |
| 69 | MP0009785_altered_susceptibility_to | 0.59586691 |
| 70 | MP0003011_delayed_dark_adaptation | 0.58463698 |
| 71 | MP0002234_abnormal_pharynx_morphology | 0.58416269 |
| 72 | MP0009697_abnormal_copulation | 0.58407332 |
| 73 | MP0002184_abnormal_innervation | 0.57748975 |
| 74 | MP0000249_abnormal_blood_vessel | 0.56063061 |
| 75 | MP0009278_abnormal_bone_marrow | 0.55802835 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.54339816 |
| 77 | MP0005310_abnormal_salivary_gland | 0.53910429 |
| 78 | MP0009745_abnormal_behavioral_response | 0.53543170 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 0.53273310 |
| 80 | MP0005248_abnormal_Harderian_gland | 0.53128735 |
| 81 | MP0002233_abnormal_nose_morphology | 0.52246240 |
| 82 | MP0004036_abnormal_muscle_relaxation | 0.51464097 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 0.51156356 |
| 84 | MP0005319_abnormal_enzyme/_coenzyme | 0.50689407 |
| 85 | MP0003787_abnormal_imprinting | 0.50476529 |
| 86 | MP0005025_abnormal_response_to | 0.49560651 |
| 87 | MP0003890_abnormal_embryonic-extraembry | 0.48840673 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.47459211 |
| 89 | MP0002067_abnormal_sensory_capabilities | 0.46518943 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.45033394 |
| 91 | MP0002064_seizures | 0.44584858 |
| 92 | MP0003868_abnormal_feces_composition | 0.44348164 |
| 93 | MP0003959_abnormal_lean_body | 0.44062918 |
| 94 | MP0005360_urolithiasis | 0.43955437 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.43402611 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.43197956 |
| 97 | MP0005253_abnormal_eye_physiology | 0.41174801 |
| 98 | MP0005647_abnormal_sex_gland | 0.40886456 |
| 99 | MP0003633_abnormal_nervous_system | 0.40091653 |
| 100 | MP0001984_abnormal_olfaction | 0.39840668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 7.06465382 |
| 2 | Rectal prolapse (HP:0002035) | 6.57379217 |
| 3 | Conjugated hyperbilirubinemia (HP:0002908) | 5.61560121 |
| 4 | Petechiae (HP:0000967) | 5.35725847 |
| 5 | Abnormality of the right ventricle (HP:0001707) | 4.76271257 |
| 6 | Male infertility (HP:0003251) | 4.68625612 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.39799892 |
| 8 | Type II lissencephaly (HP:0007260) | 3.96039692 |
| 9 | Azoospermia (HP:0000027) | 3.66583943 |
| 10 | Exocrine pancreatic insufficiency (HP:0001738) | 3.65096657 |
| 11 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.54476656 |
| 12 | Hematochezia (HP:0002573) | 3.44888107 |
| 13 | Increased mean platelet volume (HP:0011877) | 3.40777139 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.39168526 |
| 15 | Abnormality of chloride homeostasis (HP:0011422) | 3.34421214 |
| 16 | Split foot (HP:0001839) | 3.29723793 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.24083716 |
| 18 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.10475401 |
| 19 | Anterior segment dysgenesis (HP:0007700) | 3.10177629 |
| 20 | Abnormal platelet volume (HP:0011876) | 3.06547496 |
| 21 | Optic nerve hypoplasia (HP:0000609) | 2.96733066 |
| 22 | Pulmonary fibrosis (HP:0002206) | 2.93198878 |
| 23 | Increased density of long bones (HP:0006392) | 2.91784344 |
| 24 | Hypophosphatemic rickets (HP:0004912) | 2.90135977 |
| 25 | Hyperventilation (HP:0002883) | 2.88970833 |
| 26 | Hypoplasia of the uterus (HP:0000013) | 2.86420204 |
| 27 | Peripheral hypomyelination (HP:0007182) | 2.81114533 |
| 28 | Fair hair (HP:0002286) | 2.78282126 |
| 29 | Enlarged kidneys (HP:0000105) | 2.71580217 |
| 30 | Ankle clonus (HP:0011448) | 2.70325819 |
| 31 | Impaired platelet aggregation (HP:0003540) | 2.65538052 |
| 32 | Abnormal platelet function (HP:0011869) | 2.65538052 |
| 33 | Spontaneous hematomas (HP:0007420) | 2.61083025 |
| 34 | Menorrhagia (HP:0000132) | 2.60814100 |
| 35 | Abnormal biliary tract morphology (HP:0012440) | 2.58309894 |
| 36 | Stomach cancer (HP:0012126) | 2.58244944 |
| 37 | Cerebellar dysplasia (HP:0007033) | 2.55428616 |
| 38 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.47877432 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.46167687 |
| 40 | Ureteral obstruction (HP:0006000) | 2.44855557 |
| 41 | Myoglobinuria (HP:0002913) | 2.44303227 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.40859382 |
| 43 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.40595824 |
| 44 | Ureteral stenosis (HP:0000071) | 2.38506523 |
| 45 | Epistaxis (HP:0000421) | 2.35013893 |
| 46 | Purpura (HP:0000979) | 2.34346778 |
| 47 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.34062732 |
| 48 | Severe visual impairment (HP:0001141) | 2.33328493 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.32799675 |
| 50 | Short hallux (HP:0010109) | 2.32176572 |
| 51 | Protruding tongue (HP:0010808) | 2.31654960 |
| 52 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.31572037 |
| 53 | Gingival bleeding (HP:0000225) | 2.28374463 |
| 54 | Retinal dysplasia (HP:0007973) | 2.27769463 |
| 55 | Inability to walk (HP:0002540) | 2.25590276 |
| 56 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.24825089 |
| 57 | Brushfield spots (HP:0001088) | 2.21525700 |
| 58 | Late onset (HP:0003584) | 2.21409608 |
| 59 | Pancreatic cysts (HP:0001737) | 2.19308200 |
| 60 | Abnormal spermatogenesis (HP:0008669) | 2.18893793 |
| 61 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.18828063 |
| 62 | Abnormality of male internal genitalia (HP:0000022) | 2.17452385 |
| 63 | Renal cortical cysts (HP:0000803) | 2.15460987 |
| 64 | Increased corneal curvature (HP:0100692) | 2.13706652 |
| 65 | Keratoconus (HP:0000563) | 2.13706652 |
| 66 | Facial hemangioma (HP:0000329) | 2.10823278 |
| 67 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.08552498 |
| 68 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.06999045 |
| 69 | Abnormality of the renal medulla (HP:0100957) | 2.06713696 |
| 70 | Glucose intolerance (HP:0000833) | 2.02899650 |
| 71 | Lissencephaly (HP:0001339) | 2.01824114 |
| 72 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.01311671 |
| 73 | Renal tubular acidosis (HP:0001947) | 2.00817907 |
| 74 | Pachygyria (HP:0001302) | 1.99795608 |
| 75 | Decreased central vision (HP:0007663) | 1.97370039 |
| 76 | Febrile seizures (HP:0002373) | 1.96748706 |
| 77 | Congenital stationary night blindness (HP:0007642) | 1.95771409 |
| 78 | Shawl scrotum (HP:0000049) | 1.94736030 |
| 79 | Hemiplegia (HP:0002301) | 1.93951121 |
| 80 | Polymicrogyria (HP:0002126) | 1.93305525 |
| 81 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.90510548 |
| 82 | Short 1st metacarpal (HP:0010034) | 1.90510548 |
| 83 | Generalized hypopigmentation of hair (HP:0011358) | 1.84975134 |
| 84 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.83845143 |
| 85 | Gastrointestinal dysmotility (HP:0002579) | 1.82268219 |
| 86 | Capillary hemangiomas (HP:0005306) | 1.78454865 |
| 87 | Broad-based gait (HP:0002136) | 1.78435947 |
| 88 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.75300861 |
| 89 | Abnormal pancreas size (HP:0012094) | 1.74456030 |
| 90 | Nephronophthisis (HP:0000090) | 1.73880112 |
| 91 | Albinism (HP:0001022) | 1.72679108 |
| 92 | Abnormality of the labia minora (HP:0012880) | 1.71524898 |
| 93 | Agitation (HP:0000713) | 1.71434863 |
| 94 | Medial flaring of the eyebrow (HP:0010747) | 1.70860669 |
| 95 | Tented upper lip vermilion (HP:0010804) | 1.69511541 |
| 96 | Vacuolated lymphocytes (HP:0001922) | 1.68525960 |
| 97 | Abnormality of the 1st metacarpal (HP:0010009) | 1.68328489 |
| 98 | Hyperlipoproteinemia (HP:0010980) | 1.67176456 |
| 99 | Abnormality of the anterior chamber (HP:0000593) | 1.66431748 |
| 100 | Bulbous nose (HP:0000414) | 1.64168317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 4.65767712 |
| 2 | PIM2 | 3.62038489 |
| 3 | PRKG2 | 2.79065779 |
| 4 | MAP3K10 | 2.54663613 |
| 5 | WNK3 | 2.10710114 |
| 6 | MAP4K2 | 2.06152455 |
| 7 | LMTK2 | 12.1418432 |
| 8 | STK38L | 1.95962314 |
| 9 | BRAF | 1.87393845 |
| 10 | RAF1 | 1.80810735 |
| 11 | EIF2AK1 | 1.61486243 |
| 12 | TEC | 1.46716320 |
| 13 | FRK | 1.43573671 |
| 14 | ZAK | 1.34033295 |
| 15 | NUAK1 | 1.29750445 |
| 16 | EPHA3 | 1.27476897 |
| 17 | DMPK | 1.19306816 |
| 18 | VRK2 | 1.14426264 |
| 19 | DYRK2 | 1.08629774 |
| 20 | NLK | 1.05288243 |
| 21 | PDK2 | 1.05287279 |
| 22 | TNK2 | 1.05078055 |
| 23 | TNIK | 1.02461924 |
| 24 | KDR | 1.01809779 |
| 25 | INSRR | 0.92766741 |
| 26 | PRKCE | 0.90629721 |
| 27 | TAOK3 | 0.89501523 |
| 28 | GRK5 | 0.82468091 |
| 29 | STK24 | 0.80559398 |
| 30 | PRKCI | 0.79463451 |
| 31 | PLK2 | 0.77465009 |
| 32 | PHKG1 | 0.76900892 |
| 33 | PHKG2 | 0.76900892 |
| 34 | ADRBK2 | 0.75974866 |
| 35 | MAP3K4 | 0.72889741 |
| 36 | GRK1 | 0.71616687 |
| 37 | HIPK2 | 0.71464707 |
| 38 | TRIM28 | 0.71001604 |
| 39 | STK39 | 0.66357389 |
| 40 | PIK3CA | 0.65160049 |
| 41 | AKT3 | 0.64806722 |
| 42 | PRKCQ | 0.64609116 |
| 43 | ROCK1 | 0.63850627 |
| 44 | BMX | 0.62659478 |
| 45 | MAP2K7 | 0.61752304 |
| 46 | RPS6KA5 | 0.61297738 |
| 47 | PTK2B | 0.60948584 |
| 48 | TRPM7 | 0.55175457 |
| 49 | MAPKAPK3 | 0.54293519 |
| 50 | OXSR1 | 0.52377415 |
| 51 | RPS6KA2 | 0.51248482 |
| 52 | FLT3 | 0.50700390 |
| 53 | RPS6KA6 | 0.48801679 |
| 54 | DAPK2 | 0.48206343 |
| 55 | BMPR1B | 0.46752351 |
| 56 | PRKAA1 | 0.45955983 |
| 57 | MAP2K4 | 0.45793399 |
| 58 | MAPK13 | 0.42524232 |
| 59 | BCR | 0.42344248 |
| 60 | RPS6KC1 | 0.41778656 |
| 61 | RPS6KL1 | 0.41778656 |
| 62 | PIM1 | 0.40073888 |
| 63 | PKN1 | 0.37961347 |
| 64 | TAF1 | 0.37324550 |
| 65 | DYRK1A | 0.37029142 |
| 66 | STK38 | 0.36600607 |
| 67 | ICK | 0.35545670 |
| 68 | PAK3 | 0.35033753 |
| 69 | CAMK2G | 0.33861396 |
| 70 | PRKD1 | 0.33298568 |
| 71 | EPHA4 | 0.32799329 |
| 72 | DAPK1 | 0.31626389 |
| 73 | PNCK | 0.31261186 |
| 74 | MAPK11 | 0.31144263 |
| 75 | MARK1 | 0.30767140 |
| 76 | PKN2 | 0.28663747 |
| 77 | PRKAA2 | 0.27136830 |
| 78 | CHEK2 | 0.26069733 |
| 79 | PBK | 0.25768789 |
| 80 | PRKG1 | 0.24916080 |
| 81 | GRK6 | 0.24822241 |
| 82 | CSNK1G3 | 0.24549794 |
| 83 | SGK2 | 0.23944069 |
| 84 | CAMKK2 | 0.23697139 |
| 85 | CSNK1G1 | 0.23642729 |
| 86 | PRKACA | 0.23410033 |
| 87 | DDR2 | 0.23226023 |
| 88 | VRK1 | 0.22687858 |
| 89 | MAP3K12 | 0.22626734 |
| 90 | PRKCG | 0.21859238 |
| 91 | PRKACG | 0.21478663 |
| 92 | ADRBK1 | 0.20810463 |
| 93 | MAPKAPK5 | 0.20427579 |
| 94 | GRK7 | 0.20363531 |
| 95 | FGFR1 | 0.19863545 |
| 96 | MELK | 0.18366063 |
| 97 | PRKCH | 0.18303631 |
| 98 | MYLK | 0.18009215 |
| 99 | ERBB2 | 0.17907029 |
| 100 | MAPK3 | 0.16725925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ABC transporters_Homo sapiens_hsa02010 | 2.97518525 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.88970018 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.43092290 |
| 4 | Bile secretion_Homo sapiens_hsa04976 | 2.34112349 |
| 5 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.33469267 |
| 6 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.24995787 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 2.06783871 |
| 8 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.06433143 |
| 9 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.01907615 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90084545 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87989355 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.87650617 |
| 13 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.87561123 |
| 14 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87464737 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.75584479 |
| 16 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74127371 |
| 17 | Long-term depression_Homo sapiens_hsa04730 | 1.73191117 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62041269 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.60409043 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.58774077 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.47788063 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41826297 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.40344651 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.36579285 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.36094534 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.35864910 |
| 27 | Hepatitis C_Homo sapiens_hsa05160 | 1.34527633 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.30481314 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.29384648 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.26878759 |
| 31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20522682 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.20205951 |
| 33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19613454 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19292819 |
| 35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17648655 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.13158027 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.09945018 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02064344 |
| 39 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.99166769 |
| 40 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.98253230 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 0.97910966 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97754586 |
| 43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97202134 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96951606 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96019625 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95674588 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94913931 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92021988 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91584121 |
| 50 | Endometrial cancer_Homo sapiens_hsa05213 | 0.91390484 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86937680 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86918299 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 0.86052985 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84781810 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82768857 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.81775732 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 0.78463621 |
| 58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75308179 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75123185 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74854766 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73657792 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73531307 |
| 63 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73473662 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73376950 |
| 65 | Mineral absorption_Homo sapiens_hsa04978 | 0.71530310 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71244883 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69788266 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64848518 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63519520 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62607639 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.62513678 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62185568 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62034390 |
| 74 | GABAergic synapse_Homo sapiens_hsa04727 | 0.62015269 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.60227039 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58775145 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.57629796 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57595357 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56828746 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56721987 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52611454 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51485791 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49254340 |
| 84 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48892991 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.48486222 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47620778 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47396203 |
| 88 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47013711 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46395479 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43742913 |
| 91 | Protein export_Homo sapiens_hsa03060 | 0.43653155 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43261678 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42473597 |
| 94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42137230 |
| 95 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41786005 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.41772346 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41712527 |
| 98 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41485429 |
| 99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.38334223 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.35791106 |

